TY - JOUR
T1 - Herpes zoster infection in adults with rheumatic diseases in Colombia
T2 - A real world-data analysis
AU - Correa-Gonzalez, Néstor
AU - Fernández-Ávila, Daniel G.
AU - Sandoval, Diana
AU - Rosselli, Diego
N1 - Publisher Copyright:
© 2025 Egyptian Society for Joint Diseases and Arthritis
PY - 2025/6
Y1 - 2025/6
N2 - Aim of the work: To determine the prevalence of herpes zoster (HZ) infection in adults over 18 years old in Colombia and its association with immune-mediated diseases or rheumatic diseases (RDs). Patients and methods: The official database of the Ministry of Health of Colombia was analyzed for a period of five years. Information was taken from people over 18 years of age who consulted the system due to HZ infection. To estimate the prevalence per thousand inhabitants, the total number of individuals treated during that five-year period was used as the denominator. To calculate the prevalence ratio (PR), the prevalence of HZ in individuals with each associated immune-mediated disease or RDs was taken as the numerator, over the prevalence in individuals of the same sex and age group without the associated disease. Results: The unadjusted prevalence of HZ infection per 1000 adults was 7.15 (7.87 in women, 6.3 in men). In those aged 65 and older, the prevalence was 12.63/1000 (13.57 in women, 11.46 in men). In the adult general population, one in 127 women and one in 159 men will suffer an HZ infection, with the risk increasing to one in 64 in women and one in 87 men in those over 65-years-of-age. Overall, with all conditions combined, the risk increases three-fold if the patient has any of the associated conditions. Conclusions: A high prevalence of HZ infection was found in immune-mediated diseases and RDs. This information should be considered by decision makers to improve the prevention of HZ infection.
AB - Aim of the work: To determine the prevalence of herpes zoster (HZ) infection in adults over 18 years old in Colombia and its association with immune-mediated diseases or rheumatic diseases (RDs). Patients and methods: The official database of the Ministry of Health of Colombia was analyzed for a period of five years. Information was taken from people over 18 years of age who consulted the system due to HZ infection. To estimate the prevalence per thousand inhabitants, the total number of individuals treated during that five-year period was used as the denominator. To calculate the prevalence ratio (PR), the prevalence of HZ in individuals with each associated immune-mediated disease or RDs was taken as the numerator, over the prevalence in individuals of the same sex and age group without the associated disease. Results: The unadjusted prevalence of HZ infection per 1000 adults was 7.15 (7.87 in women, 6.3 in men). In those aged 65 and older, the prevalence was 12.63/1000 (13.57 in women, 11.46 in men). In the adult general population, one in 127 women and one in 159 men will suffer an HZ infection, with the risk increasing to one in 64 in women and one in 87 men in those over 65-years-of-age. Overall, with all conditions combined, the risk increases three-fold if the patient has any of the associated conditions. Conclusions: A high prevalence of HZ infection was found in immune-mediated diseases and RDs. This information should be considered by decision makers to improve the prevention of HZ infection.
KW - Epidemiology
KW - Herpes Zoster
KW - Herpes Zoster vaccine
KW - Immune-mediated disease
KW - Prevalence
KW - Rheumatic diseases
UR - http://www.scopus.com/inward/record.url?scp=105003112795&partnerID=8YFLogxK
U2 - 10.1016/j.ejr.2025.04.007
DO - 10.1016/j.ejr.2025.04.007
M3 - Article
AN - SCOPUS:105003112795
SN - 1110-1164
VL - 47
SP - 143
EP - 147
JO - Egyptian Rheumatologist
JF - Egyptian Rheumatologist
IS - 3
ER -